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Molecular Biosciences, Northwestern University, Evanston, IllinoisABSTRACT Binding of selectins to P-selectin glycoprotein ligand-1 (PSGL-1) mediates tethering and rolling of leukocytes on
the endothelium during inflammation. Previous measurements obtained with a flow-chamber assay have shown that mutations
of three tyrosines at the PSGL-1 N-terminus (Y46, Y48, and Y51) increase the reverse rates and their sensitivity to the force of
bonds with P- and L-selectin. However, the effects of these mutations on the binding affinities and forward rates have not been
studied. We quantified these effects by using an adhesion frequency assay to measure two-dimensional affinity and kinetic rates
at zero force. Wild-type PSGL-1 has 2.2- to 8.5-fold higher binding affinities for P- and L-selectin than PSGL-1 mutants with two
of three tyrosines substituted by phenylalanines, and 9.6- to 49-fold higher affinities than the PSGL-1 mutant with all three
tyrosines replaced. In descending order, the affinity decreased from wild-type to Y48/51F, Y46/51F, Y46/48F, and Y46/48/
51F. The affinity differences were attributed to major changes in the forward rate and minor changes in the reverse rate,
suggesting that these tyrosines regulate the accessibility of PSGL-1 to P- and L-selectin via electrostatic interactions, which
is supported by molecular-dynamics simulations. Our results provide insights into the structure-function relationship of
receptor-ligand binding at a single-residue level.INTRODUCTIONBinding of selectins to glycoconjugates initiates the first
step of leukocyte recruitment to sites of inflammation and
injury (1–4). L-selectin, which is expressed on most leuko-
cytes, binds ligands on endothelial cells and other leuko-
cytes. P- and E-selectin, which are expressed on activated
platelets and/or endothelial cells, bind ligands on leukocytes
and tumor cells. The best-characterized selectin ligand is
P-selectin glycoprotein ligand-1 (PSGL-1), a homodimeric
leukocyte mucin with two 120-kDa subunits linked by a
disulfide bond (5). Each subunit contains an N-terminal
portion in which the binding site for P- and L-selectin
resides, a long stalk consisting of a series of decameric
repeats, a transmembrane domain, and a short cytoplasmic
tail. The association and dissociation of selectin and
PSGL-1 pair regulate leukocyte tethering and rolling on the
endothelium.
Selectin-PSGL-1 interactions depend on the molecular
structure, cellular presentation, and mechanochemical
microenvironment of the interacting molecules (1). One
key factor is sialylation and fucosylation on the branched
core-2 O-glycan (6–13). Another crucial requirement is
the sulfation of at least one of the three tyrosines at residuesSubmitted January 30, 2012, and accepted for publication July 18, 2012.
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0006-3495/12/08/0777/9 $2.0046, 48, and 51. The interactions between P-selectin lectin
(Lec) domain and PSGL-1 N-terminal peptide have been
demonstrated by the x-ray crystallographic structure of
P-selectin lectin and epidermal growth factor (EGF)-like
domains (P-LE in short) ligated with a synthesized sulfogly-
copeptide of PSGL-1 with three tyrosine sulfate residues
(Y46, Y48, and Y51) and an sLeX-modified glycan at T57
(SGP-3 in short). In combination, electrostatic and hydro-
phobic interactions at the interface form two major contacts:
1), the sLeX-modified glycan, mainly via the fucose (FUC)
that interacts with the Ca2þ ion and its nearby residues in
lectin domain; and 2), two of the three sulfated tyrosines
(Y48 and Y51) that interact with the lectin domain
via hydrogen bonds or salt bridges (8). Replacement of all
three tyrosines with phenylalanines on transfected cells
was shown to eliminate binding to P- and L-selectin
(10,12,14–17), and substitution of two of the three tyrosines
was shown to affect the dissociation kinetics and their
force dependence under shear flow (10,12,14–17). A
flow-chamber analysis of tether lifetimes suggested that
L-selectin dissociated faster from these double mutants
than wild-type (WT) PSGL-1, whereas P-selectin unbound
from double mutants with reverse rates similar to those
observed for WT PSGL-1 (10). In this analysis, the values
were predicted by zero-force extrapolation from the mea-
sured force-dependent reverse rates using the Bell model
(18). However, the bindings of PSGL-1 with P-selectin
(19) and L-selectin (20) show catch-bond behaviors that
do not obey the Bell model, raising a question abouthttp://dx.doi.org/10.1016/j.bpj.2012.07.028
FIGURE 1 (a) Schematic of the micropipette adhesion frequency assay.
778 Xiao et al.these extrapolated zero-force reverse rates. Furthermore,
the flow-chamber studies did not address how the binding
affinities and forward rates are affected by variations of
the PSGL-1 N-terminal sulfated tyrosines.
Here, we used an adhesion frequency assay (21–25) to
quantify the two-dimensional (2D) binding affinities and
zero-force kinetic rates of P- or L-selectin interacting with
WT PSGL-1 or mutants with two or all three N-terminal
tyrosines replaced by phenylalanines (double or triple
mutants). In contrast to surface plasmon resonance, which
determines the three-dimensional (3D) kinetics with one
of the interacting molecules in solution, 2D kinetics mea-
surements quantify binding with both interacting molecules
anchored on the apposing surfaces. This is biologically rele-
vant because cell adhesion molecules are expressed on the
cell surface and bind their ligands on another cell or ex-
tracellular matrix. We also performed molecular dynamics
(MD) simulations to explore the structural impact of
N-terminal tyrosines on interactions between P- or L-selec-
tin and PSGL-1. Our data indicate the importance of these
tyrosine residues for the forward rate and the accessibility
of PSGL-1 for selectin binding.Dimeric WT or mutant PSGL-1 was expressed on transfected CHO cells
expressing FucTVII and C2nT. Soluble P-selectin or L-selectin-Ig chimera
was coupled to an RBC with uniform orientation by capturing antibodies
(S12 or AP113) precoated by CrCl3 coupling. (b) PSGL-1 mutants.
PSGL-1 was mutated by replacing two of the three (double mutants) or
all three (triple mutant) sulfated tyrosines at residues 46, 48, and 51 by
phenylalanines. Only the first 17 amino acids of mature PSGL-1 are shown.MATERIALS AND METHODS
Cells
We used transfected Chinese hamster ovary (CHO) cells stably expressing
human WT or mutant PSGL-1 as previously described (10,12). We refer to
PSGL-1 with tyrosines (green) replaced by phenylalanines (red) at residues
46, 48, and/or 51 of the N-terminal region as Y46/48F, Y46/51F, and
Y48/51F for double mutants, and Y46/48/51F for the triple mutant
(cf. Fig. 1 b). CHO cells were transfected with cDNAs for both a1,3-fuco-
syltransferase VII (FucTVII) and core-2b1,6-N-acetylglucosaminyltrans-
ferase (C2GnT). A CHO cell clone expressing high levels of both
FucTVII and C2GnT was then transfected with cDNAs for WT or mutant
PSGL-1. Cells were selected and cultured in high-glucose, low-salt
Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Grand Island,
NY), supplemented with 4 mM glutamine, 200 U/ml penicillin,
200 mg/ml streptomycin, 1% 100 HT, 1% 100 nonessential amino
acid (Hyclone, Logan, UT), 600 mg/ml geneticin (Gibco), 100 mg/ml
Hygromycin B (Boehringer Mannheim, Indianapolis, IN), 10% fetal bovine
serum, and 200 mg/ml Zeocin (Invitrogen, Carlsbad, CA), where geneticin,
Hygromycin B, and Zeocin were used as selection agents for FucTVII,
C2GnT, and PSGL-1, respectively. Control cells were cultured without
Zeocin. PSGL-1 expression was periodically checked by flow cytometry
(FACSCalibur; BD Biosciences, San Jose, CA). Before micropipette exper-
iments were conducted, the cells were detached by 5 mM PBS/EDTA,
washed with HBSSþ, and resuspended in culture media.Proteins and antibodies
Soluble P-selectin, L-selectin IgG Fc chimera, anti-P-selectin block-
ing (G1), and capturing (S12) mAbs (26–28), anti-L-selectin blocking
(DREG56), and anti-PSGL-1 blocking (PL1) mAbs (all mIgG1) are
described elsewhere (19,20). P-selectin IgG Fc chimera was purchased
from R&D Systems (Minneapolis, MN). Goat anti-human IgG Fc capturing
antibody (AP113; mIgG1) was from Chemicon (Temecula, CA). Fluores-
cein isothiocyanate (FITC)-conjugated goat anti-mouse polyclonal anti-
body and irrelevant control mIgG1 were obtained from Sigma ChemicalBiophysical Journal 103(4) 777–785(St. Louis, MO). FITC-labeled Fab fragment of rabbit anti-goat IgG was
purchased from Jackson ImmunoResearch (West Grove, PA).Coating proteins onto red blood cells
Human red blood cells (RBCs) were isolated from fresh blood of healthy
volunteers. A chromium chloride (CrCl3) protocol was used to covalently
coat capturingmAbs (S12 or AP113), anti-PSGL-1mAb (PL1), or irrelevant
mIgG onto RBC surface (24,29). Coating efficiency was analyzed by flow
cytometry (30). Antibody-coated RBCs were incubated with 200 ng/ml of
selectin constructs at room temperature for 40 min. This coating procedure
resulted in uniform orientation of P- or L-selectin on the RBC surface, which
is optimal for micropipette kinetics measurements (22).Site density determination
Site densities of WT or mutant PSGL-1s on CHO cells were measured by
flow cytometry. Cells were incubated with 10 mg/ml anti-PSGL-1 mAb
PL1 in FACS buffer (RPMI/5 mM EDTA/1% BSA/0.02% sodium azide)
on ice for 40 min and with FITC-labeled goat anti-mouse antibody on ice
for another 30 min. After washing, cells were resuspended in PBS and
analyzed by flow cytometry. The fluorescent intensities of the cells were
quantified by standard fluorescence calibration beads (Quantum 25; Bangs
Laboratories, Fishers, IN) to determine the mean number of molecules of
equivalent soluble fluorochrome (MESF) per cell. The MESF was divided
by the number of fluorochromes per antibody (provided by manufacturer)
and then the surface area (assuming a spherical cell of 20 mm in diameter
(10)) to convert into PSGL-1 site density, assuming monomeric antibody
binding.
Selectin-Binding Kinetics of Tyrosine-Replaced PSGL-1 779The site densities of selectins captured by mAb-coated RBCs were deter-
mined by immunoradiometric assay (IRMA) (22,25). RBCs were coated
with capturing mAbs at several densities (five to seven levels for each selec-
tin) and then segregated into two sets. One set was incubated with selectins
whose site densities were measured by IRMA. The other set was incubated
with FITC-labeled secondary antibodies, and the fluorescence intensities
were measured by flow cytometry. Plotting selectin-site density against
fluorescence intensity generates a calibration curve for calculating the
site density of P-selectin (22) or L-selectin (see Fig. S1in the Supporting
Material) from the fluorescence intensity of the capturing antibody. Simi-
larly, we measured the site densities of G1 and PL1 using flow cytometry
by incubating them with FITC-labeled secondary antibodies.FIGURE 2 (a–e) Binding specificity of PSGL-1 constructs to P-selectin.
Adhesion frequency under each condition was obtained by fitting the Pa
versus t curves to Eq. 1 and then setting t/N. The curves were obtained
using 6 to 59 cell pairs, each contacting 100 times, to estimate an adhesion
frequency for a given contact duration. Data are presented as the mean5
SE. The test of P-selectin captured by S12 has a higher adhesion frequency
than any controls and blocking tests (p < 0.01).2D kinetics measurements
The adhesion frequency assay for measuring 2D kinetics was previously
described (21,24). Briefly, ~103 selectin-coated RBCs and ~102 PSGL-1-
expressing CHO cells were added into a chamber solution of 50%HBSS(þ)
(8 g/L or 68.5 mMNaCl, 0.4 g/L KCl, 1 g/L glucose, 60 mg/L KH2PO4, and
47.5 mg/L Na2HPO4) and 50% H2O to swell the RBC as a mechanical
transducer. In some cases, the ionic strength of chamber solution was modi-
fied to 6 or 10 g/L NaCl in the stock HBSS solution, resulting in a final ionic
concentration of 51.5 or 85.5 mM NaCl, respectively. An RBC and a CHO
cell were each aspirated by a micropipette and driven by a computer-
controlled piezoelectric translator to go through an approach-contact-
withdrawal cycle. The repeated manipulations were performed on a light
microscope and monitored with a camera (Fig. 1 a). The suction pressure
was kept the same to set the same cell stiffness (25). An adhesion event
was determined from the RBC membrane deflection during withdrawal.
An adhesion probability, Pa, at a given contact duration, t, was determined
from 100 repeated tests. For each molecular pair examined, two Pa versus
t curves corresponding to two receptor-site densities (mr) and a single
ligand-site density (ml) were obtained from 76–133 cell pairs. Each curve







to calculate a zero-force reverse rate, kr
0, and effective binding affinity,
AcKa
0, where Ac is the contact area kept constant in all experiments.
Equation 1 is an approximate solution of master equations from a probabi-
listic model of small system kinetics and has been widely used to determine
the binding affinity and kinetic rates for various molecular systems (e.g.,
selectin, integrin, and antibody binding to their counterpart molecules)
(25,31,32). Thus, we obtained two sets of (kr
0, AcKa
0) values for each selec-
tin-PSGL-1 pair, which allowed us to calculate their mean and standard
deviation. The statistical significance of the difference between the 2D
affinities (or reverse rates) of WT and mutated PSGL-1 was determined
using Student’s t-test.MD simulations
To elucidate the structural bases of P-selectin binding to PSGL-1, we per-
formed free MD simulations using the crystal structure of WT P-LE ligated
with SGP-3. SGP-3 is a 19 amino acid sulfoglycopeptide of the PSGL-1
N-terminal region that includes three tyrosine sulfate residues (Y46, Y48,
and Y51) and an sLex-modified glycan at T57 (PDB code: 1G1S) (8). We
built the PSGL-1 double mutants Y46/48F, Y46/51F, and Y48/51F; triple
mutant Y46/48/51F; and single mutants Y48F, Y48E, and Y48R by replac-
ing the respective tyrosine residues by phenylalanines, glutamic acid, or
arginine. The strontium ion Sr2þ was replaced by calcium ion Ca2þ. Every
simulation system was established by solvating the target molecule into
a water sphere. The complex surface was covered by at least four to five
water shells and neutralized with Naþ and Cl ions to mimic the physiolog-
ical ionic concentration. Energy minimization of 5000 steps and systemheating to 300 K over 25,000 steps were performed for a>3 ns equilibration
using a NAMD program (33). A CHARMM22 all-atom force field for
protein (34) and a custom-built force field for six sugar and three tyro-
sine-sulfate residues in SGP-3 ligand (35) were used. The simulations
were performed with a time step of 1 fs, a uniform dielectric constant of
1.0, a cutoff of nonbonded interactions with a switching function starting
at a distance of 11 A˚ and reaching zero at 14 A˚, and a scaling factor of
1.0 for one to four interactions. During equilibration with a thermal bath
of 300 K, the temperature was controlled with the use of Langevin
dynamics. The water molecules in the outer 5 A˚ shell enclosing the system
were harmonically restrained to their positions to maintain the water bubble
shape, with periodic readjustment every 300 ps. The system was built up
and data analyses were performed using the VMD program (36).RESULTS
Binding controls
We quantified the binding of cells transfected with WT or
mutant PSGL-1 (Fig. 1 b) to RBCs bearing selectins using
the steady-state adhesion frequency, which we estimated
by extrapolating the adhesion frequency versus time curve
to infinite contact time (t/N) to test ligand binding selec-
tivity and nonspecific binding controls. As shown in Fig. 2,
a–d (rows 1–3), adhesions of P-selectin-bearing RBCs
to CHO cells expressing WT, Y46/48F, Y46/51F, and
Y48/51F PSGL-1 (solid-line box) were abolished when
the P-selectin capture mAb S12 was substituted with an
irrelevant mIgG1. Binding of P-selectin-bearing RBCs to
Y46/48/51F-expressing cells was only slightly higher than
nonspecific binding (Fig. 2 e), consistent with observations
that at least one of the three tyrosines is required for PSGL-1
to bind P-selectin (10,12). Adhesions were also abolished
when anti-PSGL-1 blocking mAb PL1, anti-P-selectin
blocking mAb G1, or calcium chelator EDTA was presentBiophysical Journal 103(4) 777–785
780 Xiao et al.(Fig. 2, a–e, rows 4–6), demonstrating binding specificity.
Similar results were obtained for binding of L-selectin-
bearing RBCs to WT and mutant PSGL-1 expressing cells
(Fig. S2, a–e). Furthermore, the adhesion frequencies
of P- and L-selectin-coupled RBCs to cells expressing
FucTVII and C2GnT without PSGL-1 were very low (data
not shown). These results demonstrate that the adhesions
measured were mediated by specific selectin-PSGL-1
interactions.FIGURE 4 Binding curves of L-selectin for WT and mutant PSGL-1.
Adhesion probability was plotted against contact duration for two densities
(indicated) of L-selectin interacting with WT (a), Y46/48F (b), Y46/51F
(c), Y48/51F (d), or Y46/48/51F (e) PSGL-1 at the indicated densities.Kinetic measurements
Adhesion probabilities were measured using the micropi-
pette assay at contact durations ranging from 0.05 to 12 s
for P-selectin (Fig. 3) and L-selectin (Fig. 4) interacting
with a WT (panel a), three double-mutant (panels b–d)
and one triple-mutant (panel e) PSGL-1 constructs, respec-
tively. Nonspecific adhesion frequency data were fitted by
Eq. 1 to obtain a nonspecific binding curve, Pn(t) (dashed
lines; data points not shown for clarity). The specific adhe-
sion probability, Pa (solid lines), was obtained by removing
Pn from the total adhesion frequency, Pt, according to Pa ¼
(Pt  Pn)/(1  Pn) (21). Pa followed a simple kinetics, ex-
hibiting a transition phase when it increased with t andFIGURE 3 Binding curves of P-selectin for WT and mutant PSGL-1.
Adhesion probability was plotted against contact duration for two densities
(indicated) of P-selectin interacting with WT (a), Y46/48F (b), Y46/51F
(c), Y48/51F (d), or Y46/48/51F (e) PSGL-1 at the indicated densities.
Experimental data (points), presented as the mean 5 SE at each contact
time and obtained from 22–38 cell pairs for each curve, were compared
with the predictions (solid lines) calculated from Eq. 1 using the averaged
best-fit kinetic parameters and the corresponding mr and ml values. The
dashed line represents nonspecific binding, obtained by fitting Eq. 1 to
the nonspecific data (for clarity, 30 data points in a–e are not shown).
Experimental data (points), presented as the mean 5 SE at each contact
time and obtained from 36–59 cell pairs for each curve, were compared
with the predictions (solid lines) calculated from Eq. 1 using the averaged
best-fit kinetic parameters and the corresponding mr and ml values.
The dashed line represents nonspecific binding, obtained by fitting Eq. 1
to the nonspecific data (for clarity, 35 data points in a–e are not shown).
Biophysical Journal 103(4) 777–785a steady phase when it reached equilibrium. The transient
phases of the P-selectin curves (Fig. 3) were longer than
those of the L-selectin curves (Fig. 4), consistent with
previous reports that PSGL-1 dissociates from L-selectin
much more rapidly than P-selectin (32). Each Pa versus
t data set was fitted by Eq. 1 to obtain two kinetic parame-
ters: the zero-force reverse rate, kr
0, and the effective
binding affinity, AcKa
0, for the selectin density. The theoret-
ical predictions (solid curves, based on the average of
two sets of kr
0 and AcKa
0 values obtained from 76–150 cells
and the corresponding selectin-site densities) describe both
Pa versus t data sets well for each PSGL-1 construct (Figs. 3
and 4), providing confidence in the validity of the model and
the reliability of the kinetic parameters.Effects of tyrosine replacements on the binding
kinetics of PSGL-1 to P-selectin
The different binding curves of WT and mutated PSGL-1
indicate different kinetics and affinities. To obtain the
same level of steady-state adhesion frequency (e.g.,
Pa (N) ~ 0.3), the Y46/51F mutant (ml ¼ 342 mm2; lower
solid curve in Fig. 3 c) required a 4.9-fold higher site density
than the WT (ml ¼ 70 mm2; lower solid curve in Fig. 3 a)
Selectin-Binding Kinetics of Tyrosine-Replaced PSGL-1 781PSGL-1. However, they required the same time to reach the
half-equilibrium binding level, t1/2. The equilibrium adhe-
sion probability Pa(N) is related to the effective binding
affinity, AcKa
0 ¼ ln[1  Pa(N)]/(mrml), and the half-
time t1/2 is related to the reverse rate, kr
0 z 0.5/t1/2 (21).
Therefore, the data indicate that the Y46/51F mutant binds
to P-selectin with a lower effective binding affinity but
a similar reverse rate, as compared with the WT PSGL-1.
This was confirmed by the kinetic parameters obtained by
fitting Eq. 1 to the Pa versus t data. The zero-force reverse
rate for the Y46/51F mutant was similar to that observed
for the WT (kr
0 ¼ 1.4 5 0.2 vs. 1.3 5 0.1 s1, p > 0.44;
Fig. 5 a), and the binding affinity for the Y46/51F mutant
was 5.6-fold lower than that for the WT (AcKa
0 ¼ (2.715
0.01)  104 vs. (1.52 5 0.29)  103 mm4, p < 0.026;
Fig. 5 b). These results suggest that replacing the two tyro-
sines at residues 46 and 51 significantly reduced the effective
forward rate of PSGL-1 for P-selectin when both molecules
were anchored on the apposing cell surfaces. Indeed, the
value calculated from Ackf
0 ¼ AcKa0  kr0 for the Y46/51F
mutant was 5.0-fold lower than that for the WT (Ackf
0 ¼
3.82  104 vs. 1.90  103 mm4$s1, p < 0.018).
Similar results were obtained for the Y46/48F and
Y48/51F mutants. Compared with the WT PSGL-1, their
binding affinities (AcKa
0 ¼ (1.79 5 0.30)  104 and
(3.94 5 0.49)  104 mm4, respectively) were 8.5- and
3.9-fold lower (p < 0.023 and p < 0.032, respectively;
Fig. 5 b). The reverse rate for the Y46/48F mutant
(2.415 0.01 s1) was slightly higher than that for the other
PSGL-1 constructs (p < 0.028). The forward rates for the
Y46/48F and Y48/51F mutants (Ackf
0 ¼ 4.31  104 and
4.07  104 mm4$s1, respectively) were similar to that
for the Y46/51F mutant but much lower than that for the
WT (p < 0.026). Therefore, replacing two of the three
PSGL-1 tyrosines by phenylalanines reduces the forward
rate for P-selectin.FIGURE 5 Kinetic parameters for PSGL-1-P-selectin binding. Data are
presented as the mean5 SE of reverse rates, kr
0 (a), and effective binding
affinities, AcKa
0 (b), for P-selectin interacting with WT (solid bars),
Y46/48F (open bars), Y46/51F (dotted bars), Y48/51F (leftward-hatched
bars), and Y46/48/51F (rightward-hatched bars) PSGL-1. The reverse
rate of WT is similar to that of Y46/51F (p > 0.44), Y48/51F (p > 0.14),
and Y46/48/51F (p > 0.06), but lower than that of 46/48 (p < 0.001).
The binding affinity of WT is higher than that of Y46/48F (p < 0.02),
Y46/51F (p < 0.03), Y48/51F (p < 0.032), and Y46/48/51F (p < 0.02).The P-selectin binding kinetics of the triple mutant
(Y46/48/51F), however, was drastically different from those
of the WT and three double mutants. Here the equilibrium
adhesion frequency was marginally higher than that of
nonspecific binding (Pa(N) ~ 0.1 in Fig. 3 e). Despite the
noisy data, the adhesion frequency curves of the triplemutant
provide a 1.2-fold higher reverse rate (kr
0¼ 1.625 0.13 s1)
but a 49-fold lower binding affinity (AcKa
0 ¼ (3.08 5
0.90)  105 mm4) than those of the WT PSGL-1 (p <
0.06 for kr
0 and p < 0.019 for AcKa
0, respectively). The
forward rate (Ackf
0¼ 5.00 105 mm4$s1) is ~8-fold lower
than those for the double mutants (p < 0.036), and 38-fold
lower than that for WT PSGL-1 (p < 0.026). These results
confirm previous observations that at least one of the three
tyrosine residues is required for PSGL-1 to access its recep-
tors (10,12).Effects of tyrosine replacements on binding
kinetics of PSGL-1 to L-selectin
To further define the functional consequences of tyrosine
replacement of PSGL-1, we studied the binding of the
PSGL-1 constructs to L-selectin. Soluble L-selectin-Ig
was captured by AP113 mAb on RBCs to interact with
PSGL-1 constructs on CHO cells. Compared with the WT
PSGL-1, the double mutants required 2.4- to 4.5-fold higher
combined site densities (mrml) to reach comparable equi-
librium adhesion frequencies (Pa(N) ~ 0.2–0.4), but similar
times to reach the half-equilibrium binding level (Fig. 4).
Fitting Eq. 1 to the Pa versus t curves yielded comparable
reverse rates for the three double mutants (kr
0 ¼ 8.4 5
0.1, 12.1 5 1.1, and 9.4 5 1.1 s1 for Y46/48F, Y46/
51F, and Y48/51F, respectively) with WT PSGL-1 (kr
0 ¼
8.25 0.06 s1; p ¼ 0.445, 0.086, and 0.695, respectively).
In contrast, the binding affinities were much lower (5.5-,
3.5-, and 2.2-fold) for the Y46/48F, Y46/51F, and
Y48/51F mutants (AcKa
0 ¼ (0.72 5 0.06)  105,
(1.16 5 0.02)  105, and (1.85 5 0.09)  105 mm4)
than that for the WT (AcKa
0 ¼ (3.985 0.49)  105 mm4;
p < 0.001, 0.002, and 0.005, respectively; Fig. 6). The
calculated forward rates were slightly varied in the Y46/
48F, Y46/51F, and Y48/51F mutants (Ackf
0 ¼ (0.60, 1.39,
and 1.73)  104 mm4$s1, respectively), but all were
significantly lower than that for the WT (Ackf
0 ¼ 3.26 
104 mm4$s1; p < 0.002, 0.005, and 0.03, respectively).
Substitutions of all three tyrosines, however, resulted in
very low binding (Pa(N) < 0.1) at densities comparable
to those obtained for the three double mutants, confirming
the lack of specific binding between the triple mutant and
L-selectin.
We compared the impact of PSGL-1 mutations on the
binding kinetics between L- and P-selectin. As expected
from the more rapid dissociation kinetics of WT PSGL-1
from L-selectin compared with P-selectin, the PSGL-1
double mutants had 3.5- to 9.1-fold higher reverse ratesBiophysical Journal 103(4) 777–785
FIGURE 6 Kinetic parameters for PSGL-1-L-selectin binding. Data are
presented as the mean5 SE of reverse rates, kr
0 (a), and effective binding
affinities, AcKa
0 (b), for L-selectin Ig chimera interacting with WT (solid
bars), Y46/48F (open bars), Y46/51F (dotted bars), Y48/51F (leftward-
hatched bars), and Y46/48/51F (rightward-hatched bars) constructs. The
reverse rate of WT is similar to that of Y46/48F (p > 0.44), Y46/51F
(p > 0.08), and Y48/51F (p > 0.69), but lower than that of Y46/48/51F
(p < 0.003). The binding affinity of WT is higher than that of Y46/48F
(p < 0.001), Y46/51F (p < 0.002), Y48/51F (p < 0.005), and Y46/48/
51F (p < 0.001).
FIGURE 7 Binding of P-selectin Fc chimera captured by AP113 mAb to
Y48/51F PSGL-1 in a final ionic concentration of 51.5 (squares), 68.5
(triangles), and 85.5 (cycles) mM NaCl. Data are presented as the
mean5 SE for three to four cell pairs at each contact time and compared
with the predictions (lines) calculated from Eq. 1 using the averaged best-
fit kinetic parameters (inset) and the corresponding mr and ml values.
The dashed line represents nonspecific binding, obtained by fitting Eq. 1
to the nonspecific data from a total of 18 cell pairs (for clarity, data points
are not shown).
782 Xiao et al.(p < 0.006), 21.3- to 24.9-fold lower binding affinities
(p < 0.015), and 2.4- to 7.2-fold lower forward rates (p ¼
0.018, 0.036, and 0.085 for Y46/48F, Y46/51F, and Y46/
48/51F, respectively) for L-selectin than for P-selectin
(Figs. 5 and 6).Effects of electrostatic interactions andmolecular
orientation of PSGL-1 on selectin binding
To test whether the binding difference between WT and
mutated PSGL-1 constructs resulted from modifying the
electrostatic interactions by replacing a negatively charged
tyrosine with a neutral phenylalanine, and/or from varying
the molecular orientation by capturing P-selectin with S12
and the L-selectin Fc chimera with AP113, we performed
two additional sets of measurements. In the first set,
P-selectin Fc chimera captured by AP113 mAb was tested
for interaction with the double mutant Y48/51F. The final
ionic strength of the chamber solution was modified from
68.5 mM to 51.5 and 85.5 mM NaCl, respectively. In the
single set of site densities of mr ¼ 14 mm2 for P-selectin
and ml ¼ 1,740 mm2 for PSGL-1, binding reached a
higher plateau but had a similar transition phase when the
ionic strength was reduced from 68.5 (triangles) to 51.5
(squares) mM (Fig. 7). Fitting these data using Eq. 1 (lines)
returned an increased binding affinity (AcKa
0¼ 1.42 105
and 1.95  105 mm4) and a similar reverse rate (kr0 ¼ 0.8
and 1.0 s1) for 68.5 and 51.5 mM, respectively. By
contrast, a similar equilibrium plateau and a fast transition
were observed when the ionic strength was increased to
85.5 (cycles) mM, which yielded a similar binding affinity
(1.44  105 mm4) but a faster reverse rate (3.0 s1; inset
in Fig. 7). These results indicate that electrostatic interac-
tions between the interacting molecules regulate their
binding kinetics.Biophysical Journal 103(4) 777–785In the second set, we tested the impact of molecular orien-
tation by comparing P-selectin captured by S12 mAb with
P-selectin Fc chimera captured by AP113 mAb. As indi-
cated in Figs. 5 and 7, we found a remarkable difference
in binding affinity (AcKa
0 ¼ 3.94  104 and 1.42 
105 mm4) but the reverse rate remained unchanged (kr
0 ¼
1.0 and 0.8 s1) for binding of Y48/51F to S12-captured
P-selectin and AP113-captured P-selectin Fc chimera,
respectively. This is consistent with our previous observa-
tion that the molecular orientation regulates the binding
affinity by altering the forward rate but not the reverse
rate (22).Structural basis of tyrosine replacement on
PSGL-1 binding to P-selectin
To elucidate the structural basis at the atomic level, we per-
formed equilibration MD simulations. The SGP-3 peptide
displayed significant conformational differences among
the WT (cyan) and the three single mutants; the three double
mutants of Y46/48F (blue), Y46/51F (red), and Y48/51F
(orange); and the triple mutant of Y46/48/51F (green),
whereas the SGP-3 O-glycan showed similar conformations
except for the two residues linking to T57 of the peptide
(Fig. 8 a). We compared the conformational differences
using electrostatic (black) and total nonbonded (gray) inter-
actions between the SGP-3 peptide and P-selectin lectin
domain (Fig. 8 b). The total nonbonded interactions were
further illustrated in all systems with similar orientations
of key binding sites between FUC of SGP-3 O-glycan and
the Ca2þ ion (Fig. 8 c), as well as comparable distances
between Ca2þ and the mass center of O3 and O4 atoms of
FUC (Fig. 8 d). These results indicate that the mutations
FIGURE 8 Structural features of P-selectin binding to PSGL-1 mutants.
(a) Superposition of interaction interfaces (3-ns snapshot) of P-selectin
lectin domain with WT, Y46/48F, Y46/51F, Y48/51F, and Y46/48/51F by
aligning the rigid regions of P-selectin lectin domain. Calcium (Ca
2þ),
O-glycan (SUG), and ligand peptide (LIG) are presented as VDW, bonds,
and newcartoon, respectively. For clarity, only the P-LE domains and three
sulfated tyrosine residues of 46, 48, and 51 in WT PSGL-1 are shown as
newcartoon and CPK, respectively. (b) Electrostatic (black) and all
nonbonded (gray) interactions between the SGP-3 peptide and P-selectin
lectin domain for the eight systems. (c) Key interactions between Ca
2þ
and the O-glycan FUC. (d) Distance between Ca
2þ and the mass center
of O3 and O4 atoms of FUC. Data are shown as the mean 5 SD of the
last 1 ns equilibration process. For clarity, the Y48E, Y48F, and Y48R
systems are not shown in panels a and c.
Selectin-Binding Kinetics of Tyrosine-Replaced PSGL-1 783of sulfated tyrosine residues affect the conformation of the
peptide but not the glycan of PSGL-1 ligand.DISCUSSION
The presence of three sulfated tyrosines at the PSGL-1
N-terminal region is crucial for the biological function of
PSGL-1, and tyrosine replacement affects its binding to se-
lectins (10,12,14–17). Here, using a micropipette adhesion
frequency assay, we further quantified the 2D kinetics of
interactions of WT as well as double and triple tyrosine
mutants of PSGL-1 with P- and L-selectin. Our results con-
firm that at least one of the three tyrosine residues at the
N-terminus of PSGL-1 is necessary to support binding to P-
and L-selectin (10,12). Our zero-force reverse-rate data for
WT PSGL-1 and P- or L-selectin are comparable to those
previously measured by flow-chamber and atomic force
microscopy techniques (10,20,22,25). In fact, the mean
values of zero-force reverse rate in the previousflow-chamber
study, extrapolated using the Bell model from cell-rolling
dynamics at various shear stresses, yield 1.1–1.8 s1 for P-se-
lectin and 8.6–18.3 s1 for L-selectin (10,12), which are close
to the data obtained here (1.0–1.4 s1 for P-selectin and
8.2–12.1 s1 for L-selectin), as summarized in Table S1.
The different mean values of the rates for double mutantsmeasured by the two techniques are within a factor of
2. The discrepancy may be due to the distinct surface pre-
sentations of selectin molecules: transfected murine L1-2
preB cells expressing human P-selectin or L-selectin were
used in the flow-chamber study, whereas P- and L-selectin
were presented with the use of capturing mAbs on RBCs in
our micropipette assay. The difference may also come from
our limited temporal resolution (22,25), which produces
less precise data, as reported in Figs. 5 a and 6 a.
Of more importance, in this work we measured 2D
binding affinities and forward rates using a micropipette
adhesion frequency assay, which revealed information that
would be unobtainable with the previous flow-chamber
technique. For example, compared with WT PSGL-1, the
double mutants reduced the binding affinities for P- and
L-selectin by one or two orders of magnitude, and reduced
the forward rates accordingly. The differences may explain
the different rolling dynamics of the PSGL-1 expressing
cells under applied shear stresses in the flow-chamber study
(10), because cell rolling is a dynamic process that involves
bond formation in the front and bond rupture in the rear,
and bond formation is governed by the forward rate whereas
bond rupture is controlled by the reverse rate. The triple
mutant has even lower forward rates and binding affinities
to P- and L-selectin. It should be pointed out that tyrosine
sulfation is also important for PSGL-1 binding. Although
robust rolling adhesion on P-selectin was found to be medi-
ated sufficiently by PSGL-1 mimics with tyrosine sulfation
(SGP3) and without tyrosine sulfation (GP1) (37), the re-
sulting rolling velocity was significantly lower for SGP3
than for GP1. These results imply that the binding capacity
is higher for the former than for the latter, which would be
consistent with the results of the work presented here, in
which we removed not only the tyrosine sulfation but also
the tyrosines themselves.
The influence of electrostatic interactions on protein-
ligand binding was predicted by theoretical calculations
(38–40) and demonstrated by experiments with different
molecules (41,42). The crystal structure of P-selectin and
an N-terminal glycosulfopeptide fragment of PSGL-1 re-
veals electrostatic interactions between selectin Lec domain
residues and the sulfate esters on tyrosines 48 and 51 but not
tyrosine 46 (8). It is conceivable that a significant confor-
mational change in the binding pocket of P-selectin (e.g.,
core-2 glycan; Figs. 7 and 8) forms electrostatic interactions
with the sulfate ester on tyrosine 46 that the crystal structure
does not capture. Our results suggest that these interac-
tions increase binding affinity primarily by augmenting
the forward rate. Substitution of charged tyrosine(s) with
neutralized phenylalanines may prevent electrostatic inter-
actions with P-selectin. This explains the reduction in the
forward rate and in turn the affinity for P-selectin. As
reported in our previous studies (22,25), the forward rate
strongly correlates with the molecular accessibility to its
counterpart molecule. In the work presented here, weBiophysical Journal 103(4) 777–785
784 Xiao et al.observed via MD simulations a significant reduction in the
electrostatic interactions between PSGL-1 and the P-selec-
tin lectin domain when the negatively charged tyrosines
were replaced by the neutral phenylalanine (Fig. 8 c). This
confirms that the reduction in forward rate most likely stems
from the defective accessibility of these PSGL-1 mutants.
The 2D affinity of WT PSGL-1 for P-selectin (AcKa ¼
1.52  103 mm4) observed here is close to the value previ-
ously obtained from a micropipette assay (25), suggesting
that the carrier property for transfected cells expressing
FucTVII and C2GnT is similar to that for HL-60 cells. The
affinity value is also consistent with reported in a previous
work (mlAcKa ¼ 0.25 mm2) (22), which yields AcKa ¼
4.0  103 mm4 calculated from the 63 mm2 PSGL-1 site
density on the HL-60 cells (25). Considering that the reverse
rates are close to 1 s1, these three reports show similar
forward rates for P-selectin binding to WT PSGL-1.
However, our P-selectin andL-selectin forward rates (Ackf
0¼
1.90  103 and 3.26  104 mm4 s1, respectively) are
higher than those reported in a biomembrane force probe
(BFP) study (Ackf
0 ¼ 1.4  104 and 5.9  105 mm4 s1,
respectively) that employed monomeric PSGL-1 constructs
and a thermal fluctuation assay (32). Because the monomeric
PSGL-1 construct was found to bind selectin with an affinity
similar to that obtained for native, dimeric PSGL-1 from
human neutrophils (11,43), the discrepancies may result
from the contact area, Ac, which acts as a multiplying factor
in the effective forward rate, Ackf
0. The thermal fluctuation
assay used two small rigid beads to present selectin and
PSGL-1, respectively, yielding a contact area 5–10 times
smaller than that obtained with our micropipette assay,
which would explain the lower effective forward rates
observed in the previous study.
In summary, our results demonstrate that specific tyro-
sine residues in PSGL-1 make major contributions to the
2D forward rates for interactions with P- and L-selectin.SUPPORTING MATERIAL
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